Xiujuan Zhu

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2021 · 201 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

Yuntao Zhang, Yunkai Yang, Xuewei Wang et al. · Frontiers of Medicine · 2022 · 25 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Antifungal drug susceptibility of oral<i>Candida albicans</i>isolates may be associated with apoptotic responses to Amphotericin B

Chengzhe Yang, Jingting Lu, Xiujuan Zhu et al. · Journal of Oral Pathology and Medicine · 2009 · 21 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants

Yuntao Zhang, Xiaotong Zheng, Wang Sheng et al. · Vaccines · 2022 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Subcellular quantitative proteomic analysis reveals host proteins involved in human cytomegalovirus infection

Fan Chai, Haoyu Li, Wei Wang et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2015 · 12 citations

Life Sciences, Microbiology, Molecular Biology +14